{
    "SPADE_UN_27035": {
        "Sequence Information": {
            "Peptide Name": "Arenicin-3 [C3,7,16,20Abu]",
            "Sequence": "GFXWYVXVYRNGVRVXYRRXN",
            "Sequence Length": 21,
            "Biological Activity": [
                "Anti-Gram+",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "A0A3F2YLM5",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/A0A3F2YLM5",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessus",
                    "Pubmed ID": "38287360",
                    "Reference": "J Biomed Sci. 2024;31:18",
                    "Author": "Casanova M, Maresca M, Poncin I, Point V, Olleik H, Boidin-Wichlacz C, Tasiemski A, Mabrouk K, Cavalier JF, Canaan S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/38287360"
                }
            ],
            "SPADE ID": "SPADE_UN_27035",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_27037",
                    "Similarity": 1.0,
                    "Sequence": "GFWYVCVYRNGVRVCYRRN"
                },
                {
                    "SPADE_ID": "SPADE_N_15887",
                    "Similarity": 0.9411764705882353,
                    "Sequence": "GFCWYVCVYRNGVRVCYRRCN"
                },
                {
                    "SPADE_ID": "SPADE_UN_06006",
                    "Similarity": 0.9411764705882353,
                    "Sequence": "GFCWYVCVYRNGVRVCYRRCN"
                }
            ],
            "Hemolytic Activity": "Human bronchial epithelial cells BEAS-2B:50% Cytotoxicity=>100 µM,Human erythrocytes:10% Hemolysis=39.3±3.2 µM,Human erythrocytes:50% Hemolysis=>100 µM",
            "Target Organism": "Mycobacterium abscessus subsp. abscessus CIP 104536T(MIC50=>100µM),Human hepatocellular carcinoma HepG2(50-60% Cytotoxicity=>100µM),Human renal carcinoma A498(50-60% Cytotoxicity=36.6±0.9µM)"
        }
    }
}